3-alkoxy-2-aminopropylamines compositions and use as cardiovascu

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514237, 514318, 514319, 514321, 514325, 514326, 514338, 514343, 514422, 544124, 544141, 544146, 544148, 544152, 544154, 544165, 546194, 546197, 546203, 546204, 546205, 546206, 546208, 546213, 546214, 546232, 546270, 546281, 548518, 548526, 548561, 548569, A61K 3140, A61K 31535, C07D29512

Patent

active

047270721

ABSTRACT:
Propylamines of the formula (I): ##STR1## and isomers thereof, particularly those enantiomers and racemates relative to the chiral carbon indicated by an asterisk (*). The propylamines can be used for the treatment of hypertension or angina in humans. A is pyrrolidine, piperidine or morpholine and B is an aromatic heterocycle, aromatic carbocycle or saturated carbocycle.

REFERENCES:
patent: Re30577 (1981-04-01), Busch et al.
patent: 3962238 (1976-06-01), Mauvernay et al.
patent: 4430338 (1984-02-01), Jansen et al.
patent: 4555514 (1985-11-01), Combourieu et al.
patent: 4645778 (1987-02-01), Monteil et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-alkoxy-2-aminopropylamines compositions and use as cardiovascu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-alkoxy-2-aminopropylamines compositions and use as cardiovascu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-alkoxy-2-aminopropylamines compositions and use as cardiovascu will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-603024

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.